As devotees take a holy dip at Mahakumbh, the Yogi government has taken significant steps to safeguard their health.

The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.

The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like diabetes, hypertension, and aging, is driving the demand for artificial ...

their carers and their physicians about the risks and benefits of dialysis. When renal failure is just one of many conditions affecting an elderly patient, renal replacement therapy might merely ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The content of the Benesch, Friedlander, Coplan & Aronoff LLP Dialysis & Nephrology Digest is for general information purposes only. It does not constitute legal advice or create an ...

Hemodialysis (HD)-related factors also alter drug clearance. Vigabatrin: in patients with renal impairment the dose should be decreased based on creatinine clearance. The effect of dialysis on ...

The late diagnosis of chronic kidney disease (CKD) is a global problem that limits the opportunity to initiate disease-modifying therapies. Artificial intelligence approaches using imaging or ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.